# An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects

> **NCT00302367** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 20 (—)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** OROS methylphenidate hydrochloride
- **DRUG:** immediate release methylphenidate hydrochloride

## Key facts

- **NCT ID:** NCT00302367
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 20 (—)
- **Last updated:** 2011-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302367, "An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00302367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*